FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

65356011000036104: Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 5 mL measure (trade product unit of use)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2733181000168117 Mylanta Double Strength reformulation oral liquid, 5 mL en Synonym Active Case sensitive Australian Medicines Terminology module
2736091000168113 Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 5 mL measure (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mylanta Double Strength reformulation oral liquid, 5 mL has manufactured dose form oral liquid true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 5 mL has unit of use measure true Inferred relationship Some 760075899
Mylanta Double Strength reformulation oral liquid, 5 mL has Australian BoSS magnesium hydroxide true Inferred relationship Some 3735994
Mylanta Double Strength reformulation oral liquid, 5 mL Is a trade product unit of use true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 5 mL Is a Mylanta Double Strength true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 5 mL Is a aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 5 mL has manufactured dose form oral liquid suspension false Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 5 mL has intended active ingredient aluminium hydroxide true Inferred relationship Some 197004678
Mylanta Double Strength reformulation oral liquid, 5 mL has Australian BoSS simethicone true Inferred relationship Some 760075898
Mylanta Double Strength reformulation oral liquid, 5 mL has intended active ingredient simethicone true Inferred relationship Some 760075898
Mylanta Double Strength reformulation oral liquid, 5 mL has Australian BoSS aluminium hydroxide true Inferred relationship Some 197004678
Mylanta Double Strength reformulation oral liquid, 5 mL has intended active ingredient magnesium hydroxide true Inferred relationship Some 3735994
Inbound Relationships Type Active Source Characteristic Refinability Group
Mylanta Double Strength reformulation oral liquid, 200 mL has TPUU True Mylanta Double Strength reformulation oral liquid, 5 mL Inferred relationship Some 1
Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 500 mL (trade product pack) has TPUU True Mylanta Double Strength reformulation oral liquid, 5 mL Inferred relationship Some 1
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle has TPUU True Mylanta Double Strength reformulation oral liquid, 5 mL Inferred relationship Some 1
Mylanta Double Strength reformulation oral liquid, 500 mL, bottle has TPUU True Mylanta Double Strength reformulation oral liquid, 5 mL Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start